Literature DB >> 25825523

Molecular Role of RNF43 in Canonical and Noncanonical Wnt Signaling.

Tadasuke Tsukiyama1, Akimasa Fukui2, Sayuri Terai1, Yoichiro Fujioka3, Keisuke Shinada1, Hidehisa Takahashi1, Terry P Yamaguchi4, Yusuke Ohba3, Shigetsugu Hatakeyama5.   

Abstract

Wnt signaling pathways are tightly regulated by ubiquitination, and dysregulation of these pathways promotes tumorigenesis. It has been reported that the ubiquitin ligase RNF43 plays an important role in frizzled-dependent regulation of the Wnt/β-catenin pathway. Here, we show that RNF43 suppresses both Wnt/β-catenin signaling and noncanonical Wnt signaling by distinct mechanisms. The suppression of Wnt/β-catenin signaling requires interaction between the extracellular protease-associated (PA) domain and the cysteine-rich domain (CRD) of frizzled and the intracellular RING finger domain of RNF43. In contrast, these N-terminal domains of RNF43 are not required for inhibition of noncanonical Wnt signaling, but interaction between the C-terminal cytoplasmic region of RNF43 and the PDZ domain of dishevelled is essential for this suppression. We further show the mechanism by which missense mutations in the extracellular portion of RNF43 identified in patients with tumors activate Wnt/β-catenin signaling. Missense mutations of RNF43 change their localization from the endosome to the endoplasmic reticulum (ER), resulting in the failure of frizzled-dependent suppression of Wnt/β-catenin signaling. However, these mutants retain the ability to suppress noncanonical Wnt signaling, probably due to interaction with dishevelled. RNF43 is also one of the potential target genes of Wnt/β-catenin signaling. Our results reveal the molecular role of RNF43 and provide an insight into tumorigenesis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25825523      PMCID: PMC4420922          DOI: 10.1128/MCB.00159-15

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses.

Authors:  S I Matsuzawa; J C Reed
Journal:  Mol Cell       Date:  2001-05       Impact factor: 17.970

Review 2.  The various roles of ubiquitin in Wnt pathway regulation.

Authors:  Daniele V F Tauriello; Madelon M Maurice
Journal:  Cell Cycle       Date:  2010-09-25       Impact factor: 4.534

Review 3.  The many ways of Wnt in cancer.

Authors:  Paul Polakis
Journal:  Curr Opin Genet Dev       Date:  2007-02       Impact factor: 5.578

Review 4.  Wnt signaling in stem and cancer stem cells.

Authors:  Jane D Holland; Alexandra Klaus; Alistair N Garratt; Walter Birchmeier
Journal:  Curr Opin Cell Biol       Date:  2013-01-21       Impact factor: 8.382

5.  Noncanonical Wnt signaling maintains hematopoietic stem cells in the niche.

Authors:  Ryohichi Sugimura; Xi C He; Aparna Venkatraman; Fumio Arai; Andrew Box; Craig Semerad; Jeffrey S Haug; Lai Peng; Xiao-Bo Zhong; Toshio Suda; Linheng Li
Journal:  Cell       Date:  2012-07-20       Impact factor: 41.582

6.  The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF.

Authors:  T Ishitani; J Ninomiya-Tsuji; S Nagai; M Nishita; M Meneghini; N Barker; M Waterman; B Bowerman; H Clevers; H Shibuya; K Matsumoto
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

7.  LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling.

Authors:  Andrei Glinka; Christine Dolde; Nadine Kirsch; Ya-Lin Huang; Olga Kazanskaya; Dierk Ingelfinger; Michael Boutros; Cristina-Maria Cruciat; Christof Niehrs
Journal:  EMBO Rep       Date:  2011-09-30       Impact factor: 8.807

8.  RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.

Authors:  Georgina L Ryland; Sally M Hunter; Maria A Doyle; Simone M Rowley; Michael Christie; Prue E Allan; David D L Bowtell; Kylie L Gorringe; Ian G Campbell
Journal:  J Pathol       Date:  2013-02       Impact factor: 7.996

Review 9.  WNT and beta-catenin signalling: diseases and therapies.

Authors:  Randall T Moon; Aimee D Kohn; Giancarlo V De Ferrari; Ajamete Kaykas
Journal:  Nat Rev Genet       Date:  2004-09       Impact factor: 53.242

10.  The structural basis of R-spondin recognition by LGR5 and RNF43.

Authors:  Po-Han Chen; Xiaoyan Chen; Zhenghong Lin; Deyu Fang; Xiaolin He
Journal:  Genes Dev       Date:  2013-06-11       Impact factor: 11.361

View more
  26 in total

1.  Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers.

Authors:  Shan Li; Marla Lavrijsen; Aron Bakker; Marcin Magierowski; Katarzyna Magierowska; Pengyu Liu; Wenhui Wang; Maikel P Peppelenbosch; Ron Smits
Journal:  Oncogene       Date:  2020-02-26       Impact factor: 9.867

2.  RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

Authors:  Tomasz Radaszkiewicz; Michaela Nosková; Kristína Gömöryová; Olga Vondálová Blanářová; Katarzyna Anna Radaszkiewicz; Markéta Picková; Ráchel Víchová; Tomáš Gybeľ; Karol Kaiser; Lucia Demková; Lucia Kučerová; Tomáš Bárta; David Potěšil; Zbyněk Zdráhal; Karel Souček; Vítězslav Bryja
Journal:  Elife       Date:  2021-10-27       Impact factor: 8.140

3.  Type XVII collagen coordinates proliferation in the interfollicular epidermis.

Authors:  Mika Watanabe; Ken Natsuga; Wataru Nishie; Yasuaki Kobayashi; Giacomo Donati; Shotaro Suzuki; Yu Fujimura; Tadasuke Tsukiyama; Hideyuki Ujiie; Satoru Shinkuma; Hideki Nakamura; Masamoto Murakami; Michitaka Ozaki; Masaharu Nagayama; Fiona M Watt; Hiroshi Shimizu
Journal:  Elife       Date:  2017-07-11       Impact factor: 8.140

4.  Toward an integrated map of genetic interactions in cancer cells.

Authors:  Benedikt Rauscher; Florian Heigwer; Luisa Henkel; Thomas Hielscher; Oksana Voloshanenko; Michael Boutros
Journal:  Mol Syst Biol       Date:  2018-02-21       Impact factor: 11.429

5.  Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells.

Authors:  Tomasz Radaszkiewicz; Vítězslav Bryja
Journal:  Cell Commun Signal       Date:  2020-06-11       Impact factor: 5.712

Review 6.  The influence of mitochondrial-directed regulation of Wnt signaling on tumorigenesis.

Authors:  Yaritza Delgado-Deida; Kibrom M Alula; Arianne L Theiss
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-06-15

Review 7.  Mutations and mechanisms of WNT pathway tumour suppressors in cancer.

Authors:  Jeroen M Bugter; Nicola Fenderico; Madelon M Maurice
Journal:  Nat Rev Cancer       Date:  2020-10-23       Impact factor: 60.716

8.  Prediction of G Protein-Coupled Receptors with SVM-Prot Features and Random Forest.

Authors:  Zhijun Liao; Ying Ju; Quan Zou
Journal:  Scientifica (Cairo)       Date:  2016-07-27

9.  A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis.

Authors:  Tadasuke Tsukiyama; Juqi Zou; Jihoon Kim; Shohei Ogamino; Yuki Shino; Takamasa Masuda; Alessandra Merenda; Masaki Matsumoto; Yoichiro Fujioka; Tomonori Hirose; Sayuri Terai; Hidehisa Takahashi; Tohru Ishitani; Keiichi I Nakayama; Yusuke Ohba; Bon-Kyoung Koo; Shigetsugu Hatakeyama
Journal:  Nat Commun       Date:  2020-09-15       Impact factor: 14.919

10.  Identification of a novel subgroup of endometrial cancer patients with loss of thyroid hormone receptor beta expression and improved survival.

Authors:  Daniel G Piqué; John M Greally; Jessica C Mar
Journal:  BMC Cancer       Date:  2020-09-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.